Form 4: Organon & Co. Director Robert Essner Reports Acquisition of Phantom Stock

Director Robert Essner reports acquisition of phantom stock units in Organon & Co. through a non-employee director savings plan.

Summary

• Robert Essner, a director of Organon & Co., filed a Form 4 disclosing changes in beneficial ownership.
• On June 7, 2024, Essner acquired 9,638.554 phantom stock units under the Organon Non-Employee Director Savings Plan.
• These phantom stock units are economically equivalent to shares of Organon common stock and will be settled in cash after termination of service as a director.
• The price of the phantom stock was $20.75.
• Essner's holdings include phantom stock acquired through dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.
• Following the reported transaction, Essner beneficially owns 36,454.813 phantom stock units.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing detailing a director's acquisition of phantom stock. It's neutral in tone and doesn't inherently indicate positive or negative sentiment, but the acquisition itself could be interpreted as a sign of confidence.

Positives

• The acquisition of phantom stock by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

• The acquisition of phantom stock by a director may have a slight positive impact on shareholder sentiment.

Key Dates